Status:
COMPLETED
mHealth to Screen for Neonatal Jaundice in Low-resource Mexican Settings: a Feasibility Study
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
Picterus AS
Instituto Mexicano del Seguro Social
Conditions:
Neonatal Jaundice
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
Neonatal jaundice (NNJ) is a common condition in newborns during the first week of life due to increased levels of bilirubin. Usually, it resolves without consequences after 7 to 10 days. However, aro...
Detailed Description
Background Neonatal jaundice (NNJ) affects a significant percentage of newborns (60%-80%) within the first 48 to 72 hours of life. Due to increased production and decreased elimination in the newborns...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Term healthy newborns
- Age 1-14 days
- Gestational age \>37 weeks
- Birthweight \> 2000 grams
- Exclusion criteria:
- Inborn diseases
- Transferred to pediatric wards for non-related neonatal jaundice treatment
- Have received phototherapy
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
611 Patients enrolled
Trial Details
Trial ID
NCT06073444
Start Date
January 1 2024
End Date
June 30 2024
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Rural Bienestar No 36
Tlacolula, Oaxaca, Mexico, 70400